임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

1상완료· Healthy Subjects
PK and Safety Comparison of DWJ445 and DWC202506 in Healthy Volunteers
리드: 대웅제약
상세 →NCT07256600
1상완료· Healthy
Drug-Drug Interaction Study to Evaluate the Effect of DWC202511 or DWC202512 With DWP16001 in Healthy Adults
리드: 대웅제약
상세 →NCT07213310
해당없음완료· Frailty in Older Adults
Allogeneic Human Mesenchymal Stem Cell Infusion for Frailty Patient
리드: 대웅제약
상세 →NCT07449364
3상완료· Essential Hypertension
A Phase III Study to Efficacy and Safety of DWC202405/DWC202313 and DWC202314 in Patients With Hypertension
리드: 대웅제약
상세 →NCT06671392
3상완료· Hypertension
Efficacy and Safety of DWC202404 and DWC202314 in Patients With Hypertension
리드: 대웅제약
상세 →NCT06682000
해당없음완료· Arthroscopic Surgery
Functional Outcomes After Hyaluronic Acid Injections Following Arthroscopy
리드: 대웅제약
상세 →NCT07468045
3상완료· Gastro Oesophageal Reflux Disease
Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease
협력: 대웅제약
상세 →NCT07326904
3상완료· Colonoscopy
Efficacy and Safety of DWJ1609 for Bowel Cleansing Before Colonoscopy;
리드: 대웅제약
상세 →NCT06062030
3상완료· Helicobacter Pylori Infection
Study to Evaluate the Efficacy and Safety of DWP14012-based Triple Therapy in Eradication of Helicobacter Pylori
리드: 대웅제약
상세 →NCT06751121
1상완료· Glabellar Lines
Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
리드: 대웅제약
상세 →NCT06212960
4상완료· Hepatitis B, Chronic
Efficacy and Safety of Switching to Vemliver From Entecavir in Chronic Hepatitis B Patients Previously Treated With Entecavir
리드: 대웅제약
상세 →NCT06000657
단계 미표기완료· Gastroesophageal Reflux Disease
Study to Evaluate the Efficacy and Safety of FEXUCLUE Tablet
리드: 대웅제약
상세 →NCT05886933
해당없음완료· Type 2 Diabetes
Periodic Use of Continuous Glucose Monitoring With Personalized Diet Interventions Using AI Camera Among Non-insulin Treated Type 2 Diabetes
협력: 대웅제약
상세 →NCT06594055
3상완료· Hypertension
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
리드: 대웅제약
상세 →NCT05643508
4상완료· Chronic Liver Disease
Study to Evaluate the Efficacy and Safety of DWJ1464 in Patients with Chronic Liver Disease
리드: 대웅제약
상세 →NCT06272630
4상완료· Low-Density-Lipoprotein-Type [LDL] Hyperlipoproteinemia
Effect of Early Initiation of Evolocumab on Lipid Profiles Changes in Patients With ACS Undergoing PCI
협력: 대웅제약
상세 →NCT05661552
단계 미표기완료· Gastroesophageal Reflux Disease
A Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
리드: 대웅제약
상세 →NCT05660122
1상완료· Drug Drug Interaction
Drug-drug Interactions Between DWP14012 and DWC202202 in Healthy Subjects
리드: 대웅제약
상세 →NCT05574374
1상완료· Diarrhea
Assessment of Elemental Impurities Level After Multiple Administration of DWJ1230 or DWB2001 in Subjects With Functional Diarrhea or Irritable Bowel Syndrome With Predominant Diarrhea.
리드: 대웅제약
상세 →NCT05816681
1상완료· Healthy Volunteers
Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic Characteristics of DWP16001 Drug A and C
리드: 대웅제약
상세 →NCT05465668
단계 미표기완료· Gastroesophageal Reflux Disease
Study to Evaluate the Improvement Effect on Subjective Symptom of FEXUCLUE Tab
리드: 대웅제약
상세 →NCT05614752
2상완료· Rash Acneiform
DWP708 for Treating Epidermal Growth Factor Receptor Inhibitor Related Skin Toxicities
리드: 대웅제약
상세 →NCT05378360
1상완료· Healthy
A Crossover Study of DWJ1525 to Evaluate the Safety and Pharmacokinetic Properties in Healthy Volunteers
리드: 대웅제약
상세 →NCT05192395
1상완료· Drug Drug Interaction
Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects
리드: 대웅제약
상세 →NCT05304845
단계 미표기완료· Gastritis
To Evaluate Improvement Effect of Subjective Symptoms of Mucotra SR Tablet in Patients With Gastritis
리드: 대웅제약
상세 →NCT06668506
단계 미표기완료· Dyslipidemia
To Investigate Blood Lipid Changes and Safety After Litorvazet® Tablets in Dyslipidemia Patients
리드: 대웅제약
상세 →NCT06866509
단계 미표기완료· Osteoporosis
Study to Investigate the Efficacy and Safety After Administration of Daewoong Zoledronic Acid for the Purpose of Treatment or Prevention of Osteoporosis
리드: 대웅제약
상세 →NCT05614778
1상완료· Healthy Subject
An Exploratory Clinical Trial to Evaluate and Compare Safety and Pharmacokinetic Characteristics After Administration of the DWJ1439, DWJ1464, DWC202108 or DWC202109 in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT05832697
1상완료· Healthy Volunteers
Study to Evaluate the Safety/Tolerability, PK and PD After Intravenous DWJ1521 Administration in Healthy Volunteers
리드: 대웅제약
상세 →NCT06508645
3상완료· Reflux Esophagitis
The Efficacy and Safety of DWP14012 in Chinese Patients With Reflux Esophagitis
리드: 대웅제약
상세 →NCT05813561
3상완료· Dry Eye
A Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry Eye
협력: 대웅제약
상세 →NCT05109702
1상완료· Phase 1 Study, Healthy Volunteers
Evaluate the Pharmacokinetics and Safety of DWP14012 Tablet A and Compare Those of DWP14012 Tablet B in Healthy Subjects
리드: 대웅제약
상세 →NCT05149274
4상완료· Gastritis
Clinical Trial to Compare Rebamipide/Nizatidine Combination Therapy With Nizatidine Monotherapy in Patients With Gastritis
리드: 대웅제약
상세 →NCT05072938
3상완료· T2DM (Type 2 Diabetes Mellitus)
Study to Evaluate the Long Term Safety and Efficacy of DWP16001 Compared to Placebo in the Treatment of T2DM.
리드: 대웅제약
상세 →NCT05376930
4상완료· Gastric Cancer
To Evaluate Efficacy of Ursodeoxycholic Acid (UDCA) for the Prevention of Gallstone Formation After Gasterectomy
리드: 대웅제약
상세 →NCT05410535
1상완료· Idiopathic Pulmonary Fibrosis
To Evaluate Drug-drug Interactions Between DWN12088 and Pirfenidone or Nintedanib in Healthy Volunteers
리드: 대웅제약
상세 →NCT04888715
1상완료· Idiopathic Pulmonary Fibrosis
To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy Volunteers
리드: 대웅제약
상세 →NCT04888728
해당없음완료· Type 2 Diabetes Mellitus
Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2)
리드: 대웅제약
상세 →NCT04926623
3상완료· T2DM (Type 2 Diabetes Mellitus)
Evaluate the Long Term Safety and Efficacy of DWP16001 add-on to Metformin in Patients With T2DM Inadequately Controlled on Metformin
리드: 대웅제약
상세 →NCT05376969
3상완료· Peptic Ulcer
Study to Evaluate the Efficacy and Safety of DWP14012 in Prevention of NSAIDs Induced Peptic Ulcer
리드: 대웅제약
상세 →NCT04784910
1상완료· Healthy
Pharmacokinetics and Safety Following Administration of DWP16001
리드: 대웅제약
상세 →NCT05414591
1상완료· Idiopathic Pulmonary Fibrosis
To Evaluate Food Effect on the PK and Safety After Oral DWN12088 Administration in Healthy Adult Volunteers
리드: 대웅제약
상세 →NCT04767815
1상완료· Healthy
Safety and Pharmacokinetics Evaluation Study According to the Dose of Camostat Mesylate in Healthy Volunteers
리드: 대웅제약
상세 →NCT04782505
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy Nad Safety of DWP16001 Compared to Active Drug in the Treatment of Type 2 Diabetes Mellitus
리드: 대웅제약
상세 →NCT04654390
1상완료· Covid19
To Assess the Safety, Tolerability and Pharmacokinetic Properties of Niclosamide Injectable (DWRX2003) Which is the Treatment of COVID-19 in Healthy Volunteers.
리드: 대웅제약
상세 →NCT04749173
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy and Safety of DWP16001 in Combination With Metformin in Patients With Type 2 Diabetes.
리드: 대웅제약
상세 →NCT04634500
1상완료· Covid19
Therapeutic Study to Evaluate the Safety and Efficacy of DW-MSC in COVID-19 Patients
협력: 대웅제약
상세 →NCT04535856
3상완료· T2DM (Type 2 Diabetes Mellitus)
The Efficacy and Safety of DWP16001 Compared to Placebo in the Treatment of Type 2 Diabetes Mellitus.
리드: 대웅제약
상세 →NCT04632862
1상완료· Drug-drug Interaction
Pharmacokinetic Interaction Between DWP14012 and DWC202005 in Healthy Volunteers
리드: 대웅제약
상세 →NCT04328766
3상완료· Moderate to Severe Glabellar Lines
DWP450 for Treating Moderate to Severe Glabellar Lines
리드: 대웅제약
상세 →NCT06354127
해당없음완료· Stroke
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
협력: 대웅제약
상세 →NCT05889026
3상완료· Acute Gastritis
Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis
리드: 대웅제약
상세 →NCT04341454
3상완료· Benign Masseteric Hypertrophy
Efficacy and Safety of DWP450 in Subjects With Benign Masseteric Hypertrophy
리드: 대웅제약
상세 →NCT04294251
단계 미표기완료· Chronic Occlusive Arterial Disease
Multicenter, Therapeutic Use Observational Study to Evaluate the Effects of Concurrent Therapy of Sarpogrelate
리드: 대웅제약
상세 →NCT05083299
1상완료· Healthy
Pharmacokinetics and Safety, Tolerability of DWJ211in Healthy Volunteers
리드: 대웅제약
상세 →NCT04159961
단계 미표기완료· Hypertension
Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
리드: 대웅제약
상세 →NCT05184179
해당없음완료· Chronic Kidney Disease (CKD)
The Clinical Study for Evaluating The Safety And Efficacy Of Epodion®
리드: 대웅제약
상세 →NCT05373303
단계 미표기완료· Chronic Kidney Disease (CKD)
The Clinical Study to Evaluate Immunogenicity of Epodion® in Anemia Associated With CKD Patients
리드: 대웅제약
상세 →NCT05422755
4상완료· Hypertension
Clinical Trial to Evaluate the Efficacy and Safety of OLOMAX Tab
리드: 대웅제약
상세 →NCT04120753
1상완료· Healthy
Study to Evaluate Drug-Drug Interaction of DWP16001 in Combination With Metformin in Healthy Male Adults (Phase 1 Study)
리드: 대웅제약
상세 →NCT04064073

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.